Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial.
Tatarian T, Jiang W, Leiby BE, Grigoli A, Jimbo M, Dabbish N, Neoptolemos JP, Greenhalf W, Costello E, Ghaneh P, Halloran C, Palmer D, Buchler M, Yeo CJ, Winter JM, Brody JR.
Tatarian T, et al. Among authors: winter jm.
Ann Surg. 2018 Feb;267(2):364-369. doi: 10.1097/SLA.0000000000002088.
Ann Surg. 2018.
PMID: 27893535
Free PMC article.
Clinical Trial.